Abstract
The GM2 activator is a hexosaminidase A-specific glycolipid-binding protein required for the lysosomal degradation of ganglioside GM2. Genetic deficiency of GM2 activator leads to a neurological disorder, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB). Here, we describe a G506 to C transversion (Arg169 to Pro) in the mRNA of an infantile patient suffering from GM2-gangliosidosis variant AB. Using the polymerase chain reaction amplification and direct-sequencing technique, we found the patient to be homozygous for the mutation, whereas the parents were, as expected, heterozygous. BHK cells transfected with a construct of mutant cDNA gave no GM2 activator protein detectable by the Western blotting technique, whereas those transfected by a wild-type cDNA construct showed a significant level of human GM2 activator protein. The substitution of proline for the normal Arg169 therefore appears to result in premature degradation of the mutant GM2 activator, either during the post-translational processing steps or after reaching the lysosome. The basis for the phenotype of GM2 gangliosidosis variant AB may therefore be either inactivation of the physiological activator function by the point mutation or instability of the mutant protein.
Similar content being viewed by others
References
Arlet P, Morelle C, Ausmeier M, Fitzek M, Hauser H (1988) Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene 68:213–219
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1987) Current protocols in molecular biology. Green Publishing Associates and Wiley Interscience, New York
Conzelmann E (1989) The role of activator proteins in glycolipid degradation and storage diseases. In: Azzi A, Drahota A, Papa S (eds) Molecular basis of membrane-associated diseases. Springer, Berlin Heidelberg New York, pp 379–393
Fürst W, Sandhoff K (1992) Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim Biophys Acta 1126:1–16
Klima H, Tanaka A, Schnabel D, Nakano T, Schröder M, Suzuki K, Sandhoff K (1991) Characterization of full-length cDNAs and the gene coding for the human GM2 activator protein. FEBS Lett 289:260–264
Klima H, Klein A, Echten G van, Schwarzmann G, Suzuki K, Sandhoff K (1993) Overexpression of a functionally active human GM2-activator protein in Escherichia coli. Biochem J 292:571–576
Laemmli UK (1979) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Ledeen RW, Wu G (1992) Ganglioside function in the neuron. Trends Genet 4:174
Leinekugel P, Michel S, Conzelmann E, Sandhoff K (1992) Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88:513–523
O'Brien JS, Kishimoto Y (1991) Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J 5:301–308
Sandhoff K, Conzelmann E, Neufeld EF, Kaback MM, Suzuki K (1989) The GM2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1807–1839
Schröder M, Klima H, Nakano T, Kwon H, Quintern LE, Gärtner S, Suzuki K, Sandhoff K (1989) Isolation of a cDNA encoding the human GM2 activator protein. FEBS Lett 251:197–200
Schröder M, Schnabel D, Suzuki K, Sandhoff K (1991) A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB. FEBS Lett 290:1–3
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci 76:4350–4354
Vara JA, Portela A, Ortin J, Jimenez A (1986) Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res 14:4617–4624
Xie B, Wang W, Mahuran DJ (1992) A Cys 138 to Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidoses. Am J Hum Genet 50:1046–1052
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schröder, M., Schnabel, D., Hurwitz, R. et al. Molecular genetics of GM2-gangliosidosis AB variant: a novel mutation and expression in BHK cells. Hum Genet 92, 437–440 (1993). https://doi.org/10.1007/BF00216446
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00216446